These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34229002)

  • 61. Dispersibility and Storage Stability Optimization of High Dose Isoniazid Dry Powder Inhalation Formulations with L-Leucine or Trileucine.
    Sibum I; Hagedoorn P; Kluitman MPG; Kloezen M; Frijlink HW; Grasmeijer F
    Pharmaceutics; 2019 Dec; 12(1):. PubMed ID: 31881695
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Spray freeze drying to produce a stable Delta(9)-tetrahydrocannabinol containing inulin-based solid dispersion powder suitable for inhalation.
    van Drooge DJ; Hinrichs WL; Dickhoff BH; Elli MN; Visser MR; Zijlstra GS; Frijlink HW
    Eur J Pharm Sci; 2005 Oct; 26(2):231-40. PubMed ID: 16084699
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Spray dried powders and powder blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery.
    Chan HK; Clark A; Gonda I; Mumenthaler M; Hsu C
    Pharm Res; 1997 Apr; 14(4):431-7. PubMed ID: 9144727
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Physical characteristics and aerosol performance of naringin dry powders for pulmonary delivery prepared by spray-drying.
    Sansone F; Aquino RP; Del Gaudio P; Colombo P; Russo P
    Eur J Pharm Biopharm; 2009 May; 72(1):206-13. PubMed ID: 18996478
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Preparation and physicochemical characterization of spray-dried and jet-milled microparticles containing bosentan hydrate for dry powder inhalation aerosols.
    Lee HJ; Kang JH; Lee HG; Kim DW; Rhee YS; Kim JY; Park ES; Park CW
    Drug Des Devel Ther; 2016; 10():4017-4030. PubMed ID: 28008226
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Simple and scalable method for peptide inhalable powder production.
    Schoubben A; Blasi P; Giovagnoli S; Ricci M; Rossi C
    Eur J Pharm Sci; 2010 Jan; 39(1-3):53-8. PubMed ID: 19879945
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The effect of operating and formulation variables on the morphology of spray-dried protein particles.
    Maa YF; Costantino HR; Nguyen PA; Hsu CC
    Pharm Dev Technol; 1997 Aug; 2(3):213-23. PubMed ID: 9552449
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Systemic delivery of parathyroid hormone (1-34) using spray freeze-dried inhalable particles.
    Poursina N; Vatanara A; Rouini MR; Gilani K; Rouholamini Najafabadi A
    Pharm Dev Technol; 2017 Sep; 22(6):733-739. PubMed ID: 26708720
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Particle formation and capture during spray drying of inhalable particles.
    Mosén K; Bäckström K; Thalberg K; Schaefer T; Kristensen HG; Axelsson A
    Pharm Dev Technol; 2004 Nov; 9(4):409-17. PubMed ID: 15581077
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The influence of formulation components on the aerosolisation properties of spray-dried powders.
    Rabbani NR; Seville PC
    J Control Release; 2005 Dec; 110(1):130-40. PubMed ID: 16226334
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Preparation and characterization of spray-dried powders intended for pulmonary delivery of insulin with regard to the selection of excipients.
    Razavi Rohani SS; Abnous K; Tafaghodi M
    Int J Pharm; 2014 Apr; 465(1-2):464-78. PubMed ID: 24560646
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The effects of excipients and particle engineering on the biophysical stability and aerosol performance of parathyroid hormone (1-34) prepared as a dry powder for inhalation.
    Shoyele SA; Sivadas N; Cryan SA
    AAPS PharmSciTech; 2011 Mar; 12(1):304-11. PubMed ID: 21271316
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Co-spray drying of hygroscopic kanamycin with the hydrophobic drug rifampicin to improve the aerosolization of kanamycin powder for treating respiratory infections.
    Momin MAM; Tucker IG; Doyle CS; Denman JA; Sinha S; Das SC
    Int J Pharm; 2018 Apr; 541(1-2):26-36. PubMed ID: 29458207
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dry powder formulation of kanamycin with enhanced aerosolization efficiency for drug-resistant tuberculosis.
    Momin MAM; Sinha S; Tucker IG; Doyle C; Das SC
    Int J Pharm; 2017 Aug; 528(1-2):107-117. PubMed ID: 28583333
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The use of hydrophobic amino acids in protecting spray dried trehalose formulations against moisture-induced changes.
    Mah PT; O'Connell P; Focaroli S; Lundy R; O'Mahony TF; Hastedt JE; Gitlin I; Oscarson S; Fahy JV; Healy AM
    Eur J Pharm Biopharm; 2019 Nov; 144():139-153. PubMed ID: 31536784
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Particle size and density in spray drying-effects of carbohydrate properties.
    Elversson J; Millqvist-Fureby A
    J Pharm Sci; 2005 Sep; 94(9):2049-60. PubMed ID: 16052553
    [TBL] [Abstract][Full Text] [Related]  

  • 77. How does secondary processing affect the physicochemical properties of inhalable salbutamol sulphate particles? A temporal investigation.
    Pinto JT; Radivojev S; Zellnitz S; Roblegg E; Paudel A
    Int J Pharm; 2017 Aug; 528(1-2):416-428. PubMed ID: 28619456
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Relationship between surface concentration of L-leucine and bulk powder properties in spray dried formulations.
    Mangal S; Meiser F; Tan G; Gengenbach T; Denman J; Rowles MR; Larson I; Morton DA
    Eur J Pharm Biopharm; 2015 Aug; 94():160-9. PubMed ID: 26007290
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules.
    Sou T; Kaminskas LM; Nguyen TH; Carlberg R; McIntosh MP; Morton DA
    Eur J Pharm Biopharm; 2013 Feb; 83(2):234-43. PubMed ID: 23183447
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Spray drying lactose from organic solvent suspensions for aerosol delivery to the lungs.
    Ke WR; Chang RYK; Kwok PCL; Chen D; Chan HK
    Int J Pharm; 2020 Dec; 591():119984. PubMed ID: 33069893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.